Evaluating Recent Clinical Trial Data in the Secondary Prevention of ACS

36

TAGS:

description

Evaluating Recent Clinical Trial Data in the Secondary Prevention of ACS. Disclosures. The Good News! We now have simpler and perhaps safer oral anticoagulants. Study Design Phase 2 Clinical Trials of New Anticoagulants Post-ACS. Study Designs Largely similar but a few important differences. - PowerPoint PPT Presentation

Transcript of Evaluating Recent Clinical Trial Data in the Secondary Prevention of ACS

Page 1: Evaluating Recent Clinical Trial Data in the Secondary Prevention of ACS
Page 2: Evaluating Recent Clinical Trial Data in the Secondary Prevention of ACS
Page 3: Evaluating Recent Clinical Trial Data in the Secondary Prevention of ACS
Page 4: Evaluating Recent Clinical Trial Data in the Secondary Prevention of ACS
Page 5: Evaluating Recent Clinical Trial Data in the Secondary Prevention of ACS
Page 6: Evaluating Recent Clinical Trial Data in the Secondary Prevention of ACS
Page 7: Evaluating Recent Clinical Trial Data in the Secondary Prevention of ACS
Page 8: Evaluating Recent Clinical Trial Data in the Secondary Prevention of ACS
Page 9: Evaluating Recent Clinical Trial Data in the Secondary Prevention of ACS
Page 10: Evaluating Recent Clinical Trial Data in the Secondary Prevention of ACS
Page 11: Evaluating Recent Clinical Trial Data in the Secondary Prevention of ACS
Page 12: Evaluating Recent Clinical Trial Data in the Secondary Prevention of ACS
Page 13: Evaluating Recent Clinical Trial Data in the Secondary Prevention of ACS
Page 14: Evaluating Recent Clinical Trial Data in the Secondary Prevention of ACS
Page 15: Evaluating Recent Clinical Trial Data in the Secondary Prevention of ACS
Page 16: Evaluating Recent Clinical Trial Data in the Secondary Prevention of ACS
Page 17: Evaluating Recent Clinical Trial Data in the Secondary Prevention of ACS
Page 18: Evaluating Recent Clinical Trial Data in the Secondary Prevention of ACS
Page 19: Evaluating Recent Clinical Trial Data in the Secondary Prevention of ACS
Page 20: Evaluating Recent Clinical Trial Data in the Secondary Prevention of ACS
Page 21: Evaluating Recent Clinical Trial Data in the Secondary Prevention of ACS
Page 22: Evaluating Recent Clinical Trial Data in the Secondary Prevention of ACS
Page 23: Evaluating Recent Clinical Trial Data in the Secondary Prevention of ACS
Page 24: Evaluating Recent Clinical Trial Data in the Secondary Prevention of ACS
Page 25: Evaluating Recent Clinical Trial Data in the Secondary Prevention of ACS
Page 26: Evaluating Recent Clinical Trial Data in the Secondary Prevention of ACS
Page 27: Evaluating Recent Clinical Trial Data in the Secondary Prevention of ACS
Page 28: Evaluating Recent Clinical Trial Data in the Secondary Prevention of ACS
Page 29: Evaluating Recent Clinical Trial Data in the Secondary Prevention of ACS
Page 30: Evaluating Recent Clinical Trial Data in the Secondary Prevention of ACS
Page 31: Evaluating Recent Clinical Trial Data in the Secondary Prevention of ACS
Page 32: Evaluating Recent Clinical Trial Data in the Secondary Prevention of ACS
Page 33: Evaluating Recent Clinical Trial Data in the Secondary Prevention of ACS
Page 34: Evaluating Recent Clinical Trial Data in the Secondary Prevention of ACS
Page 35: Evaluating Recent Clinical Trial Data in the Secondary Prevention of ACS
Page 36: Evaluating Recent Clinical Trial Data in the Secondary Prevention of ACS

Evaluating Embarcadero Trial Apps on the AppWave Public Storedocs.embarcadero.com › ... › AppWave_4.1_TrialApps_EN.pdf · 8 evaluating embarcadero trial apps on the appwave public

Evaluating Embarcadero Trial Apps on the AppWave Public Storedocs.embarcadero.com › ... › AppWave_4.1_TrialApps_EN.pdf · 8 evaluating embarcadero trial apps on the appwave public

Study protocol for a randomised trial evaluating the ...

Study protocol for a randomised trial evaluating the ...

AURELIA: A randomized phase III trial evaluating ......AURELIA: A randomized phase III trial evaluating bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian

AURELIA: A randomized phase III trial evaluating ......AURELIA: A randomized phase III trial evaluating bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian

Prasugrel vs. Clopidogrel for Acute Coronary Syndromes Patients Managed without Revascularization — the TRILOGY ACS trial On behalf of the TRILOGY ACS.

Prasugrel vs. Clopidogrel for Acute Coronary Syndromes Patients Managed without Revascularization — the TRILOGY ACS trial On behalf of the TRILOGY ACS.

SECOND QUARTER 2020 REPORT Ultimovacs ASAasia.blob.euroland.com/...ASA-Q220-Report.pdf · The INITIUM trial is a randomized, comparative, multi-center Phase II trial for evaluating

SECOND QUARTER 2020 REPORT Ultimovacs ASAasia.blob.euroland.com/...ASA-Q220-Report.pdf · The INITIUM trial is a randomized, comparative, multi-center Phase II trial for evaluating

Final Trial Report - Microsoft...Final Trial Report Trial code: SP 36 (W2018.012) Title: Evaluating treatments for control of lettuce root aphid on lettuce Crop Group: Field vegetables

Final Trial Report - Microsoft...Final Trial Report Trial code: SP 36 (W2018.012) Title: Evaluating treatments for control of lettuce root aphid on lettuce Crop Group: Field vegetables

Surgery Network Newsletter€¦ · He also reviewed ongoing trials including the TOPGEAR trial and ARTIST 2 trial evaluating different multi-modal management strategies. The CLASSIC

Surgery Network Newsletter€¦ · He also reviewed ongoing trials including the TOPGEAR trial and ARTIST 2 trial evaluating different multi-modal management strategies. The CLASSIC

A Randomized Controlled Trial Evaluating Lanolin for the Treatment ...

A Randomized Controlled Trial Evaluating Lanolin for the Treatment ...

PE-TIDES-ACS Trial LBT ESC2017 - hexacath.com · Minimizes Thrombus Formation Reduce Inflammation Promotes Endothelial Healing Titanium-Nitride-Oxide coated BAS Ideal stent for ACS?

PE-TIDES-ACS Trial LBT ESC2017 - hexacath.com · Minimizes Thrombus Formation Reduce Inflammation Promotes Endothelial Healing Titanium-Nitride-Oxide coated BAS Ideal stent for ACS?

Results of a Randomized Controlled Trial : Evaluating ...managingepilepsywell.org/documents/presentations/WebEase AES Pos… · Results of a Randomized Controlled Trial : Evaluating

Results of a Randomized Controlled Trial : Evaluating ...managingepilepsywell.org/documents/presentations/WebEase AES Pos… · Results of a Randomized Controlled Trial : Evaluating

A single-center phase 2 open-label trial evaluating the ...

A single-center phase 2 open-label trial evaluating the ...

From trials evaluating drugs to trials evaluating treatment algorithms – Focus on the SHIVA trial

From trials evaluating drugs to trials evaluating treatment algorithms – Focus on the SHIVA trial

The SELECT-ACS Trial

The SELECT-ACS Trial

BEATRICE Trial Evaluating the Addition of … › sites › default › files › 5mjc › 5...2013/04/04  · BEatrICE trial Evaluating the addition of Bevacizumab to adjuvant Chemotherapy

BEATRICE Trial Evaluating the Addition of … › sites › default › files › 5mjc › 5...2013/04/04  · BEatrICE trial Evaluating the addition of Bevacizumab to adjuvant Chemotherapy

The ACUITY Trial randomized 13,819 patients with moderate and high-risk NSTE-ACS.

The ACUITY Trial randomized 13,819 patients with moderate and high-risk NSTE-ACS.

ACS 360 Product Overview JUL2017-6pgs · ACS 360 ez-PRO/COA Study Designer Study Monitor ez-SourceDocx ez-DIMS ez-Consent ACS360 enables paperless clinical trial data capture that

ACS 360 Product Overview JUL2017-6pgs · ACS 360 ez-PRO/COA Study Designer Study Monitor ez-SourceDocx ez-DIMS ez-Consent ACS360 enables paperless clinical trial data capture that

Randomized*clinical*trial*evaluating*the*efficacy*of*a ......1 Randomized*clinical*trial*evaluating*the*efficacy*of*a*retrievable*vena*cava*filter** inthepreventionofpulmonaryembolismrecurrence.

Randomized*clinical*trial*evaluating*the*efficacy*of*a ......1 Randomized*clinical*trial*evaluating*the*efficacy*of*a*retrievable*vena*cava*filter** inthepreventionofpulmonaryembolismrecurrence.

Re-Evaluating Competence to Stand Trial

Re-Evaluating Competence to Stand Trial

Potential Utility of rNAPC2 in ACS: Phase 2 Heparin Replacement Trial Evaluating RNAPc2 In Acute Coronary Syndromes Potential Utility of rNAPC2 in ACS:

Potential Utility of rNAPC2 in ACS: Phase 2 Heparin Replacement Trial Evaluating RNAPc2 In Acute Coronary Syndromes Potential Utility of rNAPC2 in ACS:

Novel therapeutic strategies for the prevention of stroke in ......tion: An Intervention Trial Evaluating Rosuvastatin (JUPITER) trial will determine whether treatment with an upcoming

Novel therapeutic strategies for the prevention of stroke in ......tion: An Intervention Trial Evaluating Rosuvastatin (JUPITER) trial will determine whether treatment with an upcoming